The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis

Abstract Background Pancreatic adenocarcinoma (PAAD) is a common malignancy with a very low survival rate. More and more studies have shown that SPTAN1 may be involved in the development and progression of a variety of tumors, including rectal cancer, Pancreatic adenocarcinoma, etc., and may affect...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Guo, LingYu Hu, ZhaoFeng Gao, XiaoRong Liu, XiaoDan Yang, XiaoGuang Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-024-03581-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544619684265984
author Wei Guo
LingYu Hu
ZhaoFeng Gao
XiaoRong Liu
XiaoDan Yang
XiaoGuang Wang
author_facet Wei Guo
LingYu Hu
ZhaoFeng Gao
XiaoRong Liu
XiaoDan Yang
XiaoGuang Wang
author_sort Wei Guo
collection DOAJ
description Abstract Background Pancreatic adenocarcinoma (PAAD) is a common malignancy with a very low survival rate. More and more studies have shown that SPTAN1 may be involved in the development and progression of a variety of tumors, including rectal cancer, Pancreatic adenocarcinoma, etc., and may affect their prognosis. Methods Bioinformatics technology was used to analyze the relationship between SPTAN1 expression in PAAD and immune cell infiltration, immune regulatory factors and chemokines, and cell experiments were used to verify the relationship between SPTAN1 knock down and migration, invasion, apoptosis and cycle changes of PAAD cell lines. In addition, immunohistochemical staining of SPTAN1 was performed by tissue microarray (TMA) to study the relationship between high expression of SPTAN1 and clinicopathological features and overall survival rate. Results The expression of SPTAN1 is significantly correlated with immune cell infiltration, immunomodulators, chemokines and their receptors. In addition, it was found that the knock-down of SPTAN1 inhibited the migration and invasion ability of PAAD cell lines, promoted the apoptosis of cell lines, and also affected the changes of cell cycle. Immunohistochemical staining using tissue microarray (TMA) showed that the high expression of SPTAN1 was associated with M stage (P = 0.004) and CA199 (P = 0.012), and the overall survival rate of the high expression group was significantly lower than that of the low expression group (P = 0.043). Conclusion Our results suggest that up-regulation of SPTAN1 is related to cell migration, invasion, apoptosis and cycle changes, and is associated with tumor immune invasion and poor prognosis of PAAD.
format Article
id doaj-art-c2731e3b4bc44d5787b843a20f865219
institution Kabale University
issn 1471-230X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj-art-c2731e3b4bc44d5787b843a20f8652192025-01-12T12:26:07ZengBMCBMC Gastroenterology1471-230X2025-01-0125111510.1186/s12876-024-03581-5The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosisWei Guo0LingYu Hu1ZhaoFeng Gao2XiaoRong Liu3XiaoDan Yang4XiaoGuang Wang5Department of Interventional Vascular Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong UniversityDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing UniversityDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing UniversityDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing UniversityDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing UniversityDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing UniversityAbstract Background Pancreatic adenocarcinoma (PAAD) is a common malignancy with a very low survival rate. More and more studies have shown that SPTAN1 may be involved in the development and progression of a variety of tumors, including rectal cancer, Pancreatic adenocarcinoma, etc., and may affect their prognosis. Methods Bioinformatics technology was used to analyze the relationship between SPTAN1 expression in PAAD and immune cell infiltration, immune regulatory factors and chemokines, and cell experiments were used to verify the relationship between SPTAN1 knock down and migration, invasion, apoptosis and cycle changes of PAAD cell lines. In addition, immunohistochemical staining of SPTAN1 was performed by tissue microarray (TMA) to study the relationship between high expression of SPTAN1 and clinicopathological features and overall survival rate. Results The expression of SPTAN1 is significantly correlated with immune cell infiltration, immunomodulators, chemokines and their receptors. In addition, it was found that the knock-down of SPTAN1 inhibited the migration and invasion ability of PAAD cell lines, promoted the apoptosis of cell lines, and also affected the changes of cell cycle. Immunohistochemical staining using tissue microarray (TMA) showed that the high expression of SPTAN1 was associated with M stage (P = 0.004) and CA199 (P = 0.012), and the overall survival rate of the high expression group was significantly lower than that of the low expression group (P = 0.043). Conclusion Our results suggest that up-regulation of SPTAN1 is related to cell migration, invasion, apoptosis and cycle changes, and is associated with tumor immune invasion and poor prognosis of PAAD.https://doi.org/10.1186/s12876-024-03581-5Pancreatic adenocarcinomaNonerythroid spectrin αIIPrognosis-related biomarkerClinicopathoogical characteristics
spellingShingle Wei Guo
LingYu Hu
ZhaoFeng Gao
XiaoRong Liu
XiaoDan Yang
XiaoGuang Wang
The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
BMC Gastroenterology
Pancreatic adenocarcinoma
Nonerythroid spectrin αII
Prognosis-related biomarker
Clinicopathoogical characteristics
title The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
title_full The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
title_fullStr The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
title_full_unstemmed The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
title_short The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
title_sort up regulation of sptan1 expression in pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
topic Pancreatic adenocarcinoma
Nonerythroid spectrin αII
Prognosis-related biomarker
Clinicopathoogical characteristics
url https://doi.org/10.1186/s12876-024-03581-5
work_keys_str_mv AT weiguo theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT lingyuhu theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT zhaofenggao theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaorongliu theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaodanyang theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaoguangwang theupregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT weiguo upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT lingyuhu upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT zhaofenggao upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaorongliu upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaodanyang upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis
AT xiaoguangwang upregulationofsptan1expressioninpancreaticadenocarcinomaisassociatedwithtumorimmuneinvasionandpoorclinicalprognosis